Clinical parameters such as alpha-fetoprotein (AFP), histologic grade, tumor numbers, tumor size, microvascular invasion, tumor thrombus, tumor stage (TNM), and the selection criteria for LT (Milan or UCSF criteria) have been reported as risk factors for HCC recurrence and prognosis after LT [3–8]. This evidence concerns the gene AFP and neoplasm.